BioNTech SE (BNTX) Current Deferred Tax Assets (2019 - 2022)

BioNTech SE (BNTX) has 4 years of Current Deferred Tax Assets data on file, last reported at $73.6 million in Q3 2022.

• In Q3 2022, Current Deferred Tax Assets changed N/A year-over-year to $73.6 million; the TTM figure through Sep 2022 stood at $73.6 million (changed N/A YoY), while the FY2021 annual figure was $55.5 million, up 66.19% from the prior year.
• Current Deferred Tax Assets declined to $73.6 million in Q3 2022, from $80.7 million in the prior quarter.
• Across five years, Current Deferred Tax Assets topped out at $90.6 million in Q1 2022 and bottomed at $6.5 million in Q4 2019.
• A 4-year average of $54.0 million and a median of $55.5 million in 2021 frame the typical range for Current Deferred Tax Assets.
• Annual changes were most pronounced in 2020 — Current Deferred Tax Assets soared 414.51% — and 2021, when it jumped 66.19%.
• Year by year, Current Deferred Tax Assets stood at $6.5 million in 2019, then soared by 414.51% to $33.4 million in 2020, then jumped by 66.19% to $55.5 million in 2021, then soared by 32.66% to $73.6 million in 2022.
• The last three Current Deferred Tax Assets figures came in at $73.6 million (Q3 2022), $80.7 million (Q2 2022), and $90.6 million (Q1 2022), per Business Quant data.

Peer Comparison